Search for:
  • Sign in
  • Register
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Monday, June 9, 2025
PharmaBoardroom
Sign In Register
  • Home
  • Country Reports
    • All
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Exclusive interviews
    • All
    • Latest
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Articles
    • All
    • Global
    • Latest
  • Legal & Regulatory
    • All
    • The Pharma Legal Handbook
    • Regulatory, Pricing and Reimbursement
    • Marketing, Manufacturing, Packaging and Labeling
    • Preclinical and Clinical Trials
  • Op-Eds & Contributions
  • InFigures
    • All
    • Rankings
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Library
    • All
    • InFocus
    • InFigures
    • White Papers
  • Media Kit
  • Register
  • About Us
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Egypt Pharma Report July 2019 Download

Egypt,

July 2019

Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region.

 

Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at eradicating diseases such as Hepatitis C, healthcare and life sciences firms are increasingly cognizant of the abundant opportunities that Egypt has to offer.

 

 

Topics covered in this wide-ranging new report include the changing mindset of the Egyptian state towards healthcare, the country’s evolving healthcare needs, the numerous operational obstacles that still face pharmaceutical companies doing business in Egypt, the innovative strategies being utilised to overcome them, Egyptian firms’ manufacturing prowess, and Egypt’s potential to be a pharmaceutical export hub for Africa and beyond.

Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region.

 

Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at eradicating diseases such as Hepatitis C, healthcare and life sciences firms are increasingly cognizant of the abundant opportunities that Egypt has to offer.

 

 

Topics covered in this wide-ranging new report include the changing mindset of the Egyptian state towards healthcare, the country’s evolving healthcare needs, the numerous operational obstacles that still face pharmaceutical companies doing business in Egypt, the innovative strategies being utilised to overcome them, Egyptian firms’ manufacturing prowess, and Egypt’s potential to be a pharmaceutical export hub for Africa and beyond.

See more

Legal & Regulatory

report
Buy
Tags:
Egypt, Pharma, Report
Share on Facebook Share on WhatsApp Share on Twitter Share on Linkedin Share in Email
Back
PharmaBoardroom

PharmaBoardroom Limited
Evolution House
Iceni Court, Delft Way,
Norwich, NR6 6BB UK

Latest

  • Articles
  • In Conversation
  • Facts & Figures
  • Country Reports
  • Legal & Regulatory
  • InFocus

More

  • About Us

Join Us

  • Email Newsletters
  • LinkedIn

Contact

+44 2078673717

info@stage.pharma.kalyna.dev

Legal & Privacy

  • Terms and Conditions
  • Privacy and Cookies policy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here

logo

Sign in

Forgot password? Register Now